![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Lianyungang City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Gemcitabine hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2017-076 - Rev 00
This Chemical Type CEP, issued on February 28, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2306 associated with this CEP further emphasizes